Endosense
Company

Last deal

$41.19M
Local Amount - CHF 37.4M

Amount

Series C

Stage

27.11.2013

Date

3

all rounds

$141.54M

Total amount

date founded

Financing round

General

About Company
Endosense improves safety and efficacy of cardiac arrhythmia treatment through technology.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2003

founders

Number of employees

Last funding type

Series C

IPO status

Private

Description

The company has developed the TactiCath Quartz®, which is the first force-sensing ablation catheter that provides physicians with a real-time, objective measure of contact force during the catheter ablation procedure. Endosense has conducted numerous clinical studies that show using contact force during ablation can reduce procedure time and PV gaps at 3-month invasive follow-up. Prior to force-sensing, physicians had to estimate the force applied during ablation, which could lead to risks such as perforating the heart wall or recurrence of the condition.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
VistaCare

VistaCare

DTAMedical develops and distributes medical devices for the treatment of complex wounds.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Medical

Location

39300 Loulle, France

total rounds

2

total raised

$4.93M
AtriCure

AtriCure

AtriCure Inc develops and sells surgical treatments for Afib, LAA management, and post-operative pain management.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Medical

Location

West Chester Township, OH, USA

total rounds

3

total raised

$183.5M
ElectroPhysiology Frontiers

ElectroPhysiology Frontiers

ElectroPhysiology Frontiers is a MedTech company that develops catheter ablation systems for the treatment of atrial fibrillation.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Crocetta, Torino TO, Italy
InterCure

InterCure

InterCure developed a technology platform for respiratory-based treatment of cardiovascular and pulmonary diseases.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Therapeutics, Medical Device

Location

Ra'anana, Israel

total rounds

6

total raised

$41.9M

count Of Investments

1
M&A Details
1

Acquired by

St. Jude Medical

announced date

13.08.2013

price

$170M

Financials

Funding Rounds
5
3

Number of Funding Rounds

$141.54M

Money Raised

Their latest funding was raised on 27.11.2013. Their latest investor DEFI Gestion. Their latest round Series C

Date 
Funding Round 
Investors 
Money Raised 
Lead 
27.11.2013
8
$41.19M
Local Amount - CHF 37.4M
06.03.2013
$4.3M
27.11.2012
5
$40.3M
NGN Capital

NGN Capital

NGN Capital is a New York-based venture capital firm that specializes in healthcare investments in the US and Europe.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Location

New York, NY, USA

count Of Investments

32

count Of Exists

11
NGN Capital

NGN Capital

NGN Capital is a New York-based venture capital firm that specializes in healthcare investments in the US and Europe.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Location

New York, NY, USA

count Of Investments

32

count Of Exists

11
Co-Investors
Investors
11
1

Number of lead investors

11

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series B
No
Series B, Series C
DEFI Gestion

DEFI Gestion

DEFI Gestion SA manages close to CHF 200 million in assets for institutional and individual clients.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Lausanne, Switzerland

count Of Investments

4

count Of Exists

1
VI Partners

VI Partners

VI Partners AG is a Swiss venture capital firm supporting innovative technology and healthcare companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Altendorf, Switzerland

count Of Investments

91

count Of Exists

14
Diego Braguglia

Diego Braguglia

Diego Braguglia joined VI Partners in January 2003 as a partner focusing on life-science and biotech investments. He brings over 10 years of experience in life science, medical devices and pharmaceuticals in Europe and the US. Prior to his entry into the VC industry Diego has held various managerial positions in the pharmaceuticals and medical devices sectors, as well as in biotech start ups in Europe and the US. Diego holds an M. Sc. in Microbiology from the Biocenter of the University of Basel and a Ph.D. in Molecular and Cellular Biology from the Swiss Cancer Research Institute (ISREC) in Lausanne. He is fluent in English, French Italian and German.

current job

Amal Therapeutics
Amal Therapeutics
NGN Capital

NGN Capital

NGN Capital is a New York-based venture capital firm that specializes in healthcare investments in the US and Europe.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Location

New York, NY, USA

count Of Investments

32

count Of Exists

11
Peter Johann

Peter Johann

current job

Lumendi
Lumendi

People

Founders
1
Giovanni Leo
Giovanni Leo

Giovanni Leo

Giovanni Leo joined the venture capital firm Innogest Capital in 2017 as Venture Partner and later as Partner. Prior to Innogest Giovanni was VP of R&D at St Jude Medical since the acquisition of Endosense in 2013, which he co-founded to develop a novel technology for the catheter ablation treatment of cardiac arrhythmias. Formerly he was the director of the Geneva offices for Acrostak Corp., a Boston-Scientific funded medical device company that developed the only European system for vascular brachytherapy. He was also co-founder of Isotopes and Metals Ltd., an emerging medical device company focused on technology for prostate and gynecological brachytherapy. Giovanni previously held a software quality manager position at LeCroy Corp. as well as a CERN fellowship to carry out development activity for the control system of the Large Hadron Collider (LHC). Giovanni earned an Executive MBA in Management and Corporate Finance from the HEC of Lausanne, following a degree in management engineering from Politecnico of Milano, Italy

current job

Efficient Frontier Investing
Efficient Frontier Investing

count Of Investments

1

Giovanni Leo

Employee Profiles
9
Francois Salmon

Francois Salmon

COO

Giovanni Leo

Giovanni Leo

Co-founder and CTO

Andrea Buscaglia

CFO

Activity

Recent News
0